Earnings History Data for Arrowhead Pharmaceuticals, Inc. (ARWR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes. Its products include ARC-520, ARC-521, ARC-AAT, ARC-F12, ARC-HIF2 and ARC-LPA which are in different clinical trial phase. Arrowhead Pharmaceuticals, Inc., formerly known as Arrowhead Research Corporation, is headquartered in Pasadena, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
10-05-2022 AH 4:00 PM ET
(May 10)
ARWR Arrowhead Pharmaceuticals, Inc. 3,890 0.41 0.39 -0.26 Arrowhead Pharmaceuticals GAAP EPS of $0.41 beats by $0.12, revenue of $151.8M beats by $29.65M
[5/10/2022 4:01 PM]
28.89 -5.40 
(-15.75%)
35.93 1.64 
(4.78%)
28.53 - 93.66 1,681,010 880,000 2,345
02-02-2022 AH 4:00 PM ET
(Feb 2)
ARWR Arrowhead Pharmaceuticals, Inc. 5,280 -0.60 -0.22 -0.20 Arrowhead Pharmaceuticals GAAP EPS of -$0.60 misses by $0.20, revenue of $27.4M misses by $23.64M
[2/2/2022 4:10 PM]
49.14 -3.49 
(-6.63%)
49.00 -3.63 
(-6.90%)
46.68 - 93.66 945,723 790,000 6,834
22-11-2021 AH 4:00 PM ET
(Nov 22)
ARWR Arrowhead Pharmaceuticals, Inc. 7,380 -0.61 0.04 -0.48 Arrowhead Pharmaceuticals EPS misses by $0.77, misses on revenue
[11/22/2021 4:03 PM]
70.80 1.52 
(2.19%)
69.41 0.13 
(0.19%)
56.05 - 93.66 792,591 810,000 2,403
05-08-2021 AH 4:00 PM ET
(Aug 5)
ARWR Arrowhead Pharmaceuticals, Inc. 6,950 -0.29 -0.08 -0.13 Arrowhead Pharmaceuticals EPS misses by $0.20, beats on revenue
[8/5/2021 4:02 PM]
64.75 -3.30 
(-4.85%)
67.50 -0.55 
(-0.81%)
32.86 - 93.66 1,043,348 600,000 1,782
04-05-2021 AH 4:00 PM ET
(May 4)
ARWR Arrowhead Pharmaceuticals, Inc. 7,860 -0.26 -0.09 -0.20 Arrowhead Pharmaceuticals EPS misses by $0.16, misses on revenue
[5/4/2021 4:01 PM]
66.54 0.06 
(0.09%)
66.50 0.02 
(0.03%)
30.83 - 92.60 807,436 680,000 1,475
04-02-2021 AH 4:00 PM ET
(Feb 4)
ARWR Arrowhead Pharmaceuticals, Inc. 8,360 -0.20 1.00 -0.03 Arrowhead Pharmaceuticals EPS beats by $0.04, misses on revenue
[2/4/2021 4:01 PM]
90.54 6.62 
(7.89%)
81.94 -1.98 
(-2.36%)
19.51 - 91.70 1,374,705 765,620 3,022
23-11-2020 AH 4:00 PM ET
(Nov 23)
ARWR Arrowhead Pharmaceuticals, Inc. 7,050 -0.48 0.34 0.11 Arrowhead Pharmaceuticals EPS of -$0.84
[11/23/2020 4:18 PM]
60.27 -7.93 
(-11.63%)
65.46 -2.74 
(-4.02%)
19.51 - 73.72 3,337,809 929,134 2,688
05-08-2020 AH 4:00 PM ET
(Aug 5)
ARWR Arrowhead Pharmaceuticals, Inc. 4,380 -0.13 -0.07 0.21 Arrowhead Pharmaceuticals EPS beats by $0.04, misses on revenue
[8/5/2020 4:01 PM]
41.29 -2.27 
(-5.21%)
43.60 0.04 
(0.09%)
19.51 - 73.72 604,856 783,530 3,217